Empadus 25 mg is an oral tablet manufactured by Opsonin Pharma Ltd. in Bangladesh. It contains Empagliflozin (25 mg), a Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitor, used to manage type 2 diabetes mellitus and reduce the risk of cardiovascular death in adults with established cardiovascular disease.